News

Cocoon Bioscience announces closing of a €15M funding round to scale high value proteins production

Cocoon Bioscience is an innovative manufacturer of specialty enzymes for the life science and pharma sector and growth factor proteins for the alternative protein industry.

Exclusive: Cocoon Bioscience closes $16m round to turn moths into bioreactors for cultivated meat

Cocoon Bioscience has closed a €15 million ($15.9 million) round to grow its high-value proteins business, which includes developing recombinant proteins for cultivated meat growth

The success of the CrisBio® platform demonstrates the clear value of Algenex and spurs the creation of Cocoon Bioscience SL.

This spin-out company will exploit the unique platform for the production of growth factors, focusing on the cultured meat and cellular agriculture markets.